Amphastar Pharmaceuticals Inc. (AMPH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Amphastar Pharmaceuticals...

    NASDAQ: AMPH · Real-Time Price · USD
    26.75
    0.23 (0.87%)
    At close: Oct 03, 2025, 3:59 PM
    27.20
    1.68%
    After-hours: Oct 03, 2025, 04:47 PM EDT

    Amphastar Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 712.81M 644.39M 498.99M 437.77M
    Cost of Revenue
    		 338.96M 293.27M 250.13M 238.03M
    Gross Profit
    		 373.86M 351.12M 248.86M 199.74M
    Operating Income
    		 205.42M 196.99M 107.5M 69.89M
    Interest Income
    		 10.61M 5.46M 1.32M 601K
    Pretax Income
    		 189.76M 169.38M 114.86M 84.14M
    Net Income
    		 159.52M 137.54M 91.39M 62.12M
    Selling & General & Admin
    		 94.52M 80.39M 66.59M 68.92M
    Research & Development
    		 73.91M 73.74M 74.77M 60.93M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 168.44M 154.13M 141.36M 129.85M
    Interest Expense
    		 30.34M 27.16M 1.85M 885K
    Selling & Marketing Expenses
    		 37.8M 28.85M 21.53M 17.49M
    Cost & Expenses
    		 507.39M 447.41M 391.49M 367.88M
    Income Tax Expense
    		 29.67M 31.83M 23.48M 20.63M
    Shares Outstanding (Basic)
    		 48.43M 48.27M 48.55M 47.78M
    Shares Outstanding (Diluted)
    		 52.06M 53M 52.43M 49.78M
    EPS (Basic)
    		 3.29 2.85 1.88 1.30
    EPS (Diluted)
    		 3.06 2.60 1.74 1.25
    EBITDA
    		 277.31M 240.29M 146.16M 111.78M
    EBIT
    		 220.11M 198.52M 117.89M 85.02M
    Depreciation & Amortization
    		 57.2M 41.78M 28.27M 26.75M

    Add to Watchlist